Work

Safety, tolerability, pharmacokinetics, and pharmacodynamics of a novel kappa opioid receptor agonist ZYKR1: a randomized double-blind placebo-control phase 1 study in healthy adult human participants

Year: 2023

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Naunyn-Schmiedeberg s Archives of Pharmacology

DOI: 10.1007/s00210-023-02912-9

Authors: Kevinkumar A. Kansagra, Taufik Momin, Hardik B. Patel, Chintan Shah, Gordhan Parmar, Ashok Ghoghari, Harilal V. Patel, Deven V. Parmar

Institutions: Zydus Lifesciences Limited (India), Zydus Therapeutics Inc. (United States)

Language: English

Topic: Neuropeptides and Animal Physiology

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4390145075

FWCI: 0.096

Cites: 17

Cited by: 1

Related to: 10